Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
August 2014—E1-ClipTip electronic pipettes from Thermo Fisher Scientific are designed to maintain precise sample volumes on every channel with fewer repetitions and reproducible results for multiple application types. The ClipTip technology, electronic tip ejection, intuitive personalized user interface, and adjustable tip spacing for sample transfers make the E1-ClipTip pipette an optimal solution for complex and demanding protocols.
August 2014—HTG Molecular Diagnostics announced the availability of HTG EdgeSeq miRNA Whole Transcriptome Assay for measuring the expression of 2,275 human microRNAs described in the miRBase v20 database.
August 2014—Meridian Life Science is offering a cardiac Troponin-I antibody pair for the development of highly sensitive and specific cTnl sandwich immunoassays. Both capture antibody and detection antibody vials contain 0.2 mg and store at 2°–8°C.
August 2014—Nuclea Biotechnologies has partnered with Clinical Reference Laboratory for initial CLIA assay validation and subsequent laboratory processing in support of three of Nuclea’s key tests. Initial efforts will focus on Nuclea’s flagship assay, the Oncogene Science 159 gene-based prostate cancer monitoring test, and its Nuvera breast cancer assay.
August 2014—Qiagen acquired an exclusive worldwide license to the biomarker calreticulin. Qiagen licensed the technology from CeMM Vienna, the research center for molecular medicine of the Austrian Academy of Sciences. Qiagen plans to develop a molecular diagnostic test for the CALR mutations to offer patients a clearer prognostic profile and to guide disease management.
July 2014—Xifin, the financial cloud computing company for diagnostic service providers, formed a medical advisory board that will share its extensive expertise in pathology operations and workflow, lab automation, regulatory requirements, clinician needs, and pathology informatics important to the company’s product development and strategic initiatives.
July 2014—Meridian Life Science now has a sampling kit with HIV-1 p24 reagents for developing sensitive and specific HIV-1 p24 sandwich immunoassays. The kit includes a 0.25-mg vial of capture antibody, MAb to HIV-1 p24; a 0.25-mg vial of detection antibody, MAb to HIV-1 p24; and a 0.25-mg vial of recombinant HIV-1 p24 antigen (strain HxB2) expressed in Pichia pastoris. Meridian Life Science, 901-382-8716
July 2014—To accommodate growing order volumes, BioMérieux has integrated Esker’s cloud-based order processing automation solution within its SAP environment for electronic order management. Esker’s intelligent data capture technology accurately extracts order information while automated workflow routes the orders to the appropriate customer service representative.
July 2014—Audit MicroControls added ready-to-use vitamin D linearity and control kits to its line of calibration verification/linearity and daily quality control products. These liquid, human serum–based products are intended for use with quantitative assays on clinical laboratory analyzers, simulating human patient serum samples. The Linearity LQ Vitamin D (universal) and Linearity LQ Vitamin D Roche both have five levels that demonstrate a linear relationship to each other when assayed for vitamin D, have a shelf life of two years, and an open-vial stability of 14 days when stored at 2°–8°C.
July 2014—Dako and Merck & Co. will collaborate to develop a companion diagnostic test for the analysis of the potential tumor biomarker PD-L1 to aid in the treatment of cancer. The companion diagnostic test coming out of this collaboration will be evaluated as part of the clinical development program from Merck’s investigational anti-PD-1 antibody being studied for the treatment of cancer.
